195 related articles for article (PubMed ID: 22008843)
1. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity.
Valenzuela R; Videla LA
Food Funct; 2011 Nov; 2(11):644-8. PubMed ID: 22008843
[TBL] [Abstract][Full Text] [Related]
2. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
[TBL] [Abstract][Full Text] [Related]
3. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
[TBL] [Abstract][Full Text] [Related]
4. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
[TBL] [Abstract][Full Text] [Related]
5. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c.
Dossi CG; Tapia GS; Espinosa A; Videla LA; D'Espessailles A
J Nutr Biochem; 2014 Sep; 25(9):977-84. PubMed ID: 24993917
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
9. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet.
Valenzuela R; Espinosa A; Llanos P; Hernandez-Rodas MC; Barrera C; Vergara D; Romero N; Pérez F; Ruz M; Videla LA
Food Funct; 2016 Jan; 7(1):140-50. PubMed ID: 26471014
[TBL] [Abstract][Full Text] [Related]
10. Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues.
Valenzuela R; Rincón-Cervera MÁ; Echeverría F; Barrera C; Espinosa A; Hernández-Rodas MC; Ortiz M; Valenzuela A; Videla LA
Nutrition; 2018 Jan; 45():49-58. PubMed ID: 29129237
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
[TBL] [Abstract][Full Text] [Related]
12. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease.
Valenzuela R; Ortiz M; Hernández-Rodas MC; Echeverría F; Videla LA
Curr Med Chem; 2020; 27(31):5250-5272. PubMed ID: 30968772
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients.
Elizondo A; Araya J; Rodrigo R; Poniachik J; Csendes A; Maluenda F; Díaz JC; Signorini C; Sgherri C; Comporti M; Videla LA
Obesity (Silver Spring); 2007 Jan; 15(1):24-31. PubMed ID: 17228028
[TBL] [Abstract][Full Text] [Related]
14. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
Scorletti E; Byrne CD
Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
[TBL] [Abstract][Full Text] [Related]
16. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction.
Pettinelli P; Videla LA
J Clin Endocrinol Metab; 2011 May; 96(5):1424-30. PubMed ID: 21325464
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms related to the hepatoprotective effects of antioxidant-rich extra virgin olive oil supplementation in rats subjected to short-term iron administration.
Barrera C; Valenzuela R; Rincón MÁ; Espinosa A; Echeverria F; Romero N; Gonzalez-Mañan D; Videla LA
Free Radic Biol Med; 2018 Oct; 126():313-321. PubMed ID: 30153476
[TBL] [Abstract][Full Text] [Related]
20. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
